The MHRA raided Moulton Grange, a Grade II‑listed country house in Northamptonshire, on 28 May and seized about 12,000 suspected illegal weight‑loss injections. Two men were arrested and later released while inquiries continue. Seized items included syringes labelled tirzepatide and retatrutide and packaging branded "Alluvi," a name linked to an earlier raid and recent trademark filings. The MHRA warned that medicines obtained outside licensed pharmacies may be unsafe.
About 12,000 Illegal Weight-Loss Jabs Seized in MHRA Raid on Georgian Stately Home
Black market weight-loss jab factory found in stately home
The Medicines and Healthcare products Regulatory Agency (MHRA) carried out a raid on Moulton Grange, a Grade II‑listed Georgian country house near Pitsford in Northamptonshire, on 28 May, seizing around 12,000 doses of suspected illegal weight‑loss injections. Two 29‑year‑old men were arrested and later released while inquiries continue.
Details Of The Operation
MHRA investigators described the seizure as the largest of its kind they have encountered and said they believe the activity may be linked to an organised criminal network. The agency conducted the search as part of an ongoing probe into unlicensed medicines. The MHRA declined to provide further details about the location of arrests or the identities of those detained.
Location And Property
Moulton Grange is a cream‑faced Georgian estate with chandeliers, dark wood panelling and extensive grounds—including roaming peacocks—about seven miles (11 km) north of Northampton. Land Registry records show the property sold for £2.2m in 2017 and includes roughly 28 acres, a 12‑bedroom main house and an adjoining cottage that have been used for events and short‑term lets.
The registered owners are Faiz Hameed, 61, and Rashda Hameed, 59, directors of Moulton Grange Limited. The Hameeds told the BBC the MHRA activity was confined to a separately let annexe occupied by tenants and that the main house had no involvement.
What Was Seized
Items recovered included thousands of prefilled syringes labelled as tirzepatide and retatrutide and packaging bearing the brand name "Alluvi." Tirzepatide is marketed by Eli Lilly as Mounjaro, but the MHRA said the products found were not manufactured by the company. Retatrutide is an experimental obesity medicine in clinical trials in the United States and is not approved for use in the UK.
Investigators said the packaging appeared "sophisticated" and "authentic looking," raising concerns that such products could put consumers at risk if obtained outside legitimate channels. The "Alluvi" name was also linked to packaging seized in an earlier October 2025 raid on a warehouse, and trademark applications for "Alluvi" and "Alluvi Healthcare" were filed in April 2026 by a company registered in Northampton. Any formal link between that company, the seized products and the estate has not been confirmed.
MHRA Warning: Prescription‑only medicines should only be obtained from registered pharmacies with a valid prescription. Products sourced outside legitimate supply chains offer no guarantees about safety, quality or authenticity.
Context
The Moulton Grange seizure follows other recent MHRA enforcement actions in Northamptonshire related to suspected illicit manufacture or distribution of weight‑loss injections. Authorities said this appears to be one of the first instances where an operation was producing its own branded injection rather than simply repackaging counterfeit versions of established medicines.
Investigations are ongoing. The MHRA continues to urge the public to avoid buying prescription medicines from unregulated sources and to report suspicious products or sellers to the regulator.
Help us improve.
